Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Sulfateq B.V.”

8 pharma patents match "Sulfateq B.V." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "Sulfateq B.V." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “Sulfateq B.V.” · 30,257 patents in full index Clear search

  1. US 12156862

    Medicaments for the treatment of vasoconstriction related diseases or disorders

    Sulfateq B.V. · Granted Dec 3, 2024 · Expires Nov 28, 2044

    granted
  2. US 11730741

    6-chromanol derivatives for use as a medicament

    Sulfateq B.V. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  3. US 11006626

    Compounds for protection of cells

    Sulfateq B.V. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  4. US 10676452

    Compound for the prophylaxis or treatment of organ damage

    Sulfateq B.V. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  5. US 10426771

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  6. US 10322124

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  7. US 10123529

    Compounds for protection of cells

    Sulfateq B.V. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  8. US 9913841

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted